WARRICK 1660
Pill imprint WARRICK 1660 has been identified as Theophylline extended-release 200 mg.
Theophylline is used in the treatment of asthma, maintenance; apnea of prematurity; asthma, acute and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy.
Theophylline 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Theophylline extended-release Images
- Imprint:
-
WARRICK 1660
- Strength:
- 200 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Methylxanthines
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Warrick Pharmaceuticals Corporation
Advertisement
More Theophylline Extended-Release resources
- Theophylline (Wolters Kluwer)
- Theophylline Elixir (Wolters Kluwer)
- Theophylline Sustained-Release Capsules (Wolters Kluwer)
- Theophylline Sustained-Release Tablets (Wolters Kluwer)
- theophylline (Cerner Multum)
- Norphyl (Micromedex) - Includes Dosage Information
- Phyllocontin (Micromedex) - Includes Dosage Information
- theophylline (Micromedex) - Includes Dosage Information
- theophylline Intravenous (Micromedex) - Includes Dosage Information
- Theophylline (FDA)
- Theophylline Elixir (FDA)
- Theophylline Oral Solution (FDA)
- Theophylline in Dextrose (FDA)
- Theophylline (Wolters Kluwer)
Search Again
